G11.2 Kilder

Individualisert legemiddelbehandling

FDA biomarkers table. www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm

Rooji T, Wilson DM, Marsh S. Personalized medicine policy challenges: measuring clinical utility at point of care. Expert Rev. Pharmacoecon. Outcomes Res. 2012; 12(3), 289-95

Sioud M, Melien Ø. Treatment options and individualized medicine. Methods Mol Biol. 2007;361:327-40

www.crediblemeds.org

Personalized Medicine for the European Citizen – towards more precise medicine for the diagnosis, treatment and prevention of disease. Forward Look. European Science Foundation